Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: Results of a meta-analysis of 1,528 patients from six randomized trials

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 3, 2002, Pages 219-223

  Huncharek, Michael ^a   Kupelnick, Bruce ^a  

^a Meta Analysis Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; VINCRISTINE;

ADVANCED CANCER; ARTICLE; BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NASOPHARYNX CARCINOMA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; NASOPHARYNGEAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0036275317     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200206000-00002     Document Type: Article

References (16)

1. Nasopharyngeal carcinoma: An evaluation of 134 patients treated between 1971-1980
2. An epidemiologic and clinical study of nasopharyngeal carcinoma
3. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China
4. Chemotherapy in advanced nasopharyngeal cancer
5. Beta-blockade during and after myocardial infarction: An overview of the randomized trials
6. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099
7. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
8. Preliminary report of the Asian-Oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
9. Combined therapy of undifferentiated carcinoma of nasopharyngeal type
10. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV undifferentiated nasopharyngeal carcinoma: A positive effect on progression free survival
11. Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4 year multi-center randomized study
12. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
13. Chemotherapy in advanced nasopharyngeal cancer
14. Chemotherapy for nasopharyngeal cancer: A ten year experience
15. A phase III randomized trial comparing concurrent chemotherapy-radiotherapy with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma